InvestorsHub on MSN
Omeros shares fall 4% as European regulators uphold negative opinion on Narsoplimab
Omeros Corporation (NASDAQ:OMER) shares declined 4% in Friday morning trading after the European Medicines Agency’s (EMA) ...
Omeros's narsoplimab faced two EU rejections in 2025-2026 due to EMA panels lacking access to patient-level data critical for ...
As U.S. demand rises, Omeros plans to end compassionate use; current patients will get enough drug to finish treatment. Two ...
A new review argues that sugar-based signaling through Siglec receptors and complement Factor H forms a hidden regulatory ...
Last time,“How does the body learn about vaccines?” was the starting point for reviewing live vaccines, inactivated vaccines, ...
The study was led by Shin-ichi Kano, M.D., Ph.D., professor and UAB Endowed Professor in Mental Health Research in the UAB Department of Psychiatry and Behavioral Neurobiology, and sheds light on a ...
To maximize the over $1 million allocated to establish a sustainable FIM infrastructure, the FIMC has selected three vendors to guide this work: University of Delaware, Beebe Healthcare, and Deloitte ...
The complement system has an important role in physiological bone healing, as studied mainly in animal models and local bone tissues. However, the role of the complement system in human fractures, ...
Scientists pinpoint a skin alarm system pathway that links local damage to systemic immune responses
Skin, our largest organ, acts as a protective barrier against pathogens that try to invade our bodies while constantly monitoring for potential threats. In the skin's outermost layer, the epidermis, ...
Deep in our cells, a wide range of processes are occurring constantly. These cellular processes rely on enzymes to act as catalysts and set off a series of molecular interactions. There are still many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results